Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05278039 · ClinicalTrials.gov registry record · NA

Training Swallowing Initiation During Expiration

A NA study of Head and Neck Cancer and Dysphagia, sponsored by Northwestern University.

Recruiting
Registry status
NA
Development phase
88
Enrollment target
2
Study locations

NCT05278039 is a NA study of Head and Neck Cancer and Dysphagia that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 88 participants, below the 260-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (66% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05278039, a NA study of Head and Neck Cancer and Dysphagia, is actively recruiting participants, sponsored by Northwestern University.

RECRUITING
Registry status
NA
Development phase
88 participants
Enrollment target
2
Study locations

Study Summary

Head and neck cancers have escalated to epidemic levels in the United States, and survivors are suffering from life-long, devastating swallowing disorders with limited therapeutic options. This clinical trial investigates a novel swallowing treatment that trains initiation of swallowing during the expiratory phase of respiration to improve swallowing safety and efficiency.

Interventions

  • BEHAVIORAL Respiratory-Swallow Phase Training
  • OTHER Swallow Practice

Study Locations (2)

Illinois

  • Northwestern Memorial Hospital - Chicago
  • Northwestern University - Evanston

Trial Details

FieldValue
Enrollment Target 88 participants
Start Date 2022-05-19
Est. Completion 2027-07-31
Phase NA

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT05278039

The ClinicalTrials.gov registry entry for NCT05278039 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 260-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (66% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Head and Neck Cancer appearing as the primary indexed condition, and to 2 interventions - of which Respiratory-Swallow Phase Training is the first listed.

NCT05278039 reports 2 study locations spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT05278039 about?

NCT05278039 is a clinical study titled "Training Swallowing Initiation During Expiration". Head and neck cancers have escalated to epidemic levels in the United States, and survivors are suffering from life-long, devastating swallowing disorders with limited therapeutic options. This clinical trial investigates a novel swallowing treatment that trains initiation of swallowing during the e...

What is the current status of trial NCT05278039?

This trial is currently recruiting. It is a NA study. The enrollment target is 88 participants. The study started on 2022-05-19. Estimated completion is 2027-07-31.

What conditions does trial NCT05278039 study?

This clinical trial studies the following conditions: Head and Neck Cancer, Dysphagia, Oropharyngeal Dysphagia, Oropharynx Squamous Cell Carcinoma.

What interventions are being tested in trial NCT05278039?

The interventions under investigation include: Respiratory-Swallow Phase Training (BEHAVIORAL), Swallow Practice (OTHER).

Who is sponsoring clinical trial NCT05278039?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05278039 being conducted?

This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Head and Neck Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.